pharmalundensis.se

Start - PharmaLundensis AB

PharmaLundensis AB utvecklar ett nytt läkemedel mot kronisk obstruktiv lungsjuktom KOL baserat på en ny verkningsmekanism.
traffic

OVERVIEW

This website pharmalundensis.se currently has a traffic classification of zero (the smaller the higher page views). We have explored zero pages within the domain pharmalundensis.se and found four websites referencing pharmalundensis.se.
Links to this site
4

PHARMALUNDENSIS.SE RANKINGS

This website pharmalundensis.se has seen variant amounts of traffic for the duration of the year.
Traffic for pharmalundensis.se

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for pharmalundensis.se

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for pharmalundensis.se

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB SITE

SmiLe Incubator Strengthening mankind

We help entrepreneurs and early-stage companies develop and commercialize new ideas in life science, bringing together bright minds to share powerful ideas. We want to get to know you! .

WHAT DOES PHARMALUNDENSIS.SE LOOK LIKE?

Desktop Screenshot of pharmalundensis.se Mobile Screenshot of pharmalundensis.se Tablet Screenshot of pharmalundensis.se

PHARMALUNDENSIS.SE HOST

I observed that the main root page on pharmalundensis.se took one thousand one hundred and nine milliseconds to download. Our parsers could not observe a SSL certificate, so therefore I consider this site not secure.
Load time
1.109 secs
SSL
NOT SECURE
Internet Protocol
195.35.83.154

WEBSITE IMAGE

SERVER OS

I identified that this domain is weilding the Apache operating system.

PAGE TITLE

Start - PharmaLundensis AB

DESCRIPTION

PharmaLundensis AB utvecklar ett nytt läkemedel mot kronisk obstruktiv lungsjuktom KOL baserat på en ny verkningsmekanism.

CONTENT

This website pharmalundensis.se states the following, "VÄLKOMMEN TILL PHARMALUNDENSIS AB! PharmaLundensis AB publ utvecklar följande projekt." We analyzed that the webpage stated " Ett nytt effektivt läkemedel mot lungsjukdomen." It also stated " Som hindrar utsläpp av antibiotika och multi-resistenta baktierier från sjukhusens avlopp. CE-certifierad medicinteknisk produkt Bronkitstopp mot kronisk bronkit. Patent godkänt i USA 180405. Läs Pressmeddelandet i PDF-format här."

VIEW OTHER DOMAINS

Home - Pharmalutions - from Serialisation to Track Trace

We recommend that you update your browser to the latest version.

pharmalux - Pharmalux

Was founded in 1968 by Aimilios Nikolaos Mavritsakis as a G. So in 1996 it became L. with the current name AIMILIOS NIKOLAOS MAVRITSAKIS L. Since then major shareholder and operator is his daughter Anna-Maria Mavritsakis, Biologist-Biochemical, Pharmacologist.

Pharmalys Libya

AlSahl Group is a group of Libyan companies specializes in feed, food, construction industry also providing logistic services such as oil feels services and maritime handling and logistics. We are glad to hear from you. Send us your comments and suggestions. You can also send orders online.